Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Discovering novel Cathepsin L inhibitors from natural products using artificial intelligence. Local targets link to admitted publications; unresolved targets remain external evidence.
The global burden of metabolic disease: data from 2000 to 2019
10.1016/j.cmet.2023.02.003 · 2023 · External reference
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
2022 · External reference
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas
10.1016/j.diabres.2019.107843 · 2019 · External reference
The epidemiology of obesity
10.1016/j.metabol.2018.09.005 · 2019 · External reference
New trends on obesity and NAFLD in Asia
10.1016/j.jhep.2017.06.003 · 2017 · External reference
Obesity and cardiovascular disease: a scientific statement from the American Heart Association
2021 · External reference
Global trends in diabetes complications: a review of current evidence
10.1007/s00125-018-4711-2 · 2019 · External reference
Complications of obesity
10.1093/qjmed/hcx152 · 2018 · External reference
What do we know about inequalities in NAFLD distribution and outcomes? A scoping review
10.3390/jcm10215019 · 2021 · External reference
Biosynthesis and alternate targeting of the lysosomal cysteine protease cathepsin L
2004 · External reference
Multi‐step processing of procathepsin L in vitro
10.1016/0014-5793(94)00924-4 · 1994 · External reference
Multiple processing of Procathepsin L to Cathepsin L in Vivo
10.1006/bbrc.1998.9613 · 1998 · External reference
Inhibitor studies indicate that active cathepsin L is probably essential to its own processing in cultured fibroblasts
10.1042/bj2720039 · 1990 · External reference
10.1080/14728222.2020.1746765
10.1080/14728222.2020.1746765 · External reference
All roads lead to cathepsins: the role of cathepsins in non-alcoholic steatohepatitis-induced hepatocellular carcinoma
10.3390/biomedicines10102351 · 2022 · External reference
The multifaceted role of the lysosomal protease cathepsins in kidney disease
10.3389/fcell.2017.00114 · 2017 · External reference
10.1096/fj.06-7924com
10.1096/fj.06-7924com · External reference
10.1038/ncb1623
10.1038/ncb1623 · External reference
Markers of diabetic nephropathy
10.1016/s1056-8727(97)00045-7 · 1998 · External reference
The insulin receptor: its role in insulin resistance of obesity and diabetes
10.2337/diab.25.12.1154 · 1976 · External reference
10.1016/j.tem.2015.11.009
10.1016/j.tem.2015.11.009 · External reference
Evidence suggesting a role for cathepsin L in an experimental model of glomerulonephritis
10.1016/0003-9861(91)90222-5 · 1991 · External reference
10.3390/molecules25030698
10.3390/molecules25030698 · External reference
Cathepsin B and L inhibitors: a patent review (2010-present)
10.1080/13543776.2017.1272572 · 2017 · External reference
Cathepsin L-selective inhibitors: a potentially promising treatment for COVID-19 patients
2020 · External reference
Marine natural products
10.1039/c7np00052a · 2018 · External reference
10.1038/s41573-020-00114-z
10.1038/s41573-020-00114-z · External reference
Beneficial health applications and medicinal values of Pedicularis plants: a review
10.1016/j.biopha.2017.09.041 · 2017 · External reference
Inhibition of CYP2B6 by medicinal plant extracts: implication for use of efavirenz and nevirapine-based highly active anti-retroviral therapy (HAART) in resource-limited settings
10.3390/molecules21020211 · 2016 · External reference
10.3390/molecules21050559
10.3390/molecules21050559 · External reference
Metformin: its botanical background
10.1002/pdi.606 · 2004 · External reference
10.1007/s00125-017-4318-z
10.1007/s00125-017-4318-z · External reference
Biguanide is a modifiable pharmacophore for recruitment of endogenous Zn 2+ to inhibit cysteinyl cathepsins: review and implications
10.1007/s10534-019-00197-1 · 2019 · External reference
10.4155/fmc-2019-0307
10.4155/fmc-2019-0307 · External reference
10.3390/molecules25225277
10.3390/molecules25225277 · External reference
10.1016/j.drudis.2020.10.010
10.1016/j.drudis.2020.10.010 · External reference
10.1016/j.drudis.2020.12.003
10.1016/j.drudis.2020.12.003 · External reference
Artificial intelligence in drug discovery: applications and techniques
10.1093/bib/bbab430 · 2022 · External reference
10.1146/annurev-pharmtox-010919-023324
10.1146/annurev-pharmtox-010919-023324 · External reference
Message passing neural networks
10.1007/978-3-030-40245-7_10 · 2020 · External reference
An approach combining deep learning and molecule docking for drug discovery of cathepsin L
10.1080/17460441.2023.2174522 · 2023 · External reference
RDKit: A software suite for cheminformatics, computational chemistry, and predictive modeling
2013 · External reference
Prospective evaluation of free energy calculations for the prioritization of cathepsin L inhibitors
10.1021/acs.jmedchem.6b01881 · 2017 · External reference
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
10.1007/s10822-013-9644-8 · 2013 · External reference
10.1021/acs.jctc.5b00864
10.1021/acs.jctc.5b00864 · External reference
Open babel: an open chemical toolbox
2011 · External reference
Epik: a software program for pK a prediction and protonation state generation for drug-like molecules
10.1007/s10822-007-9133-z · 2007 · External reference
Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
10.1021/jm0306430 · 2004 · External reference
RDKit: a software suite for cheminformatics, computational chemistry, and predictive modeling
2013 · External reference
10.1002/jcc.20291
10.1002/jcc.20291 · External reference
10.1038/nmeth.4067
10.1038/nmeth.4067 · External reference
Automation of the CHARMM General Force Field (CGenFF) II: assignment of bonded parameters and partial atomic charges
10.1021/ci3003649 · 2012 · External reference
A modified TIP3P water potential for simulation with Ewald summation
10.1063/1.1808117 · 2004 · External reference
10.1002/prot.22711
10.1002/prot.22711 · External reference
Sobtop: a tool of generating forcefield parameters and GROMACS topology file
2022 · External reference
10.1517/17460441.2015.1032936
10.1517/17460441.2015.1032936 · External reference
10.1021/acs.jctc.1c00645
10.1021/acs.jctc.1c00645 · External reference
Unresolved reference
External reference
The message passing neural networks for chemical property prediction on SMILES
10.1016/j.ymeth.2020.05.009 · 2020 · External reference
Analyzing learned molecular representations for property prediction
10.1021/acs.jcim.9b00237 · 2019 · External reference
10.1016/j.cell.2020.01.021
10.1016/j.cell.2020.01.021 · External reference
10.1016/j.csbj.2022.05.023
10.1016/j.csbj.2022.05.023 · External reference
10.1016/j.bioorg.2021.105256
10.1016/j.bioorg.2021.105256 · External reference
10.1016/j.bioorg.2019.103417
10.1016/j.bioorg.2019.103417 · External reference
10.1016/j.bioorg.2018.09.029
10.1016/j.bioorg.2018.09.029 · External reference
10.1007/s10534-019-00197-1
10.1007/s10534-019-00197-1 · External reference
Cathepsin L inhibition prevents murine autoimmune diabetes via suppression of CD8+ T cell activity
10.1371/journal.pone.0012894 · 2010 · External reference
Cathepsin L in COVID-19: from pharmacological evidences to genetics
10.3389/fcimb.2020.589505 · 2020 · External reference
Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies
10.1038/s41392-021-00733-x · 2021 · External reference
10.1021/acschembio.0c00875
10.1021/acschembio.0c00875 · External reference
10.1080/14756366.2022.2108417
10.1080/14756366.2022.2108417 · External reference
How artificial intelligence is changing drug discovery
10.1038/d41586-018-05267-x · 2018 · External reference
High-throughput molecular dynamics: the powerful new tool for drug discovery
10.1016/j.drudis.2012.03.017 · 2012 · External reference
New avenues in artificial-intelligence-assisted drug discovery
2023 · External reference
A mechanistic review of plumbagin effects againts diabetes and obesity
10.29090/psa.2021.06.21.071 · 2021 · External reference
10.1371/journal.pone.0047122
10.1371/journal.pone.0047122 · External reference
